Skip to main content

IMVT- Immunovant, Inc.

Across the last three months, Immunovant, Inc.'s insiders have reduced their positions by a net 110,922 shares worth roughly $4.2M. In the past 30 days, 0 insiders bought and 3 sold.

On the other side, 3 insiders reduced their position over the period. IMVT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

RoleInsiderSharesValue30d
CFO240.8K$9.86M-6,798
COO222.5K$9.11M-
Other218.0K$8.92M-
Other205.3K$8.40M-2,857
Other179.4K$7.34M-

Activity

Buys and sells only

Transactions

10 filings · page 4
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Apr 9, 2025Stout Jay S63Chief Technology OfficerSell5,004$12.99$65,001.96-2.3%+13.4%+72.1%
Apr 9, 2025Geffner Michael66Chief Medical OfficerSell6,169$12.99$80,135.31-2.6%+13.4%+72.1%
Apr 9, 2025Barnett Eva Renee58Chief Financial OfficerSell11,063$12.99$143,708.37-1.4%+13.4%+72.1%
Apr 9, 2025Salzmann Peter51Chief Executive OfficerSell28,094$12.99$364,941.06-2.3%+13.4%+72.1%
Mar 7, 2025Fromkin Andrew J.45DirectorSell8,000$19.60$156,768.96-4.1%-20.0%+33.2%
Feb 19, 2025MacIas William L.51Chief Medical OfficerSell2,055$20.86$42,867.30-0.6%-28.0%+26.6%
Feb 19, 2025Barnett Eva Renee58Chief Financial OfficerSell2,814$20.86$58,700.04-0.9%-28.0%+26.6%
Feb 19, 2025Salzmann Peter51Chief Executive OfficerSell15,439$20.86$322,057.54-1.6%-28.0%+26.6%
Jan 22, 2025Stout Jay S63Chief Technology OfficerSell2,195$23.59$51,780.05-1.5%-38.7%+12.7%
Jan 22, 2025Geffner Michael66Chief Medical OfficerSell2,657$23.59$62,678.63-2.0%-38.7%+12.7%

Understand these filings